{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:46:52Z","timestamp":1792169212074,"version":"4.4.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2026,11,5]]},"DOI":"10.1038\/s41416-026-03568-x","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:56:47Z","timestamp":1785520607000},"page":"1512-1523","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Spatial proteomics deciphers the immune niche landscape of non-ampullary duodenal adenocarcinoma"],"prefix":"10.1038","volume":"135","author":[{"given":"Yuichiro","family":"Kohara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minako","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuko","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanari","family":"Tatsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taichi","family":"Terai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Osamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotaro","family":"Matsuhisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Yoshizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6208-7661","authenticated-orcid":false,"given":"Masayuki","family":"Sho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"3568_CR1","doi-asserted-by":"publisher","first-page":"e158","DOI":"10.1016\/j.canep.2012.01.008","volume":"36","author":"Y Lu","year":"2012","unstructured":"Lu Y, Fr\u00f6bom R, Lagergren J. Incidence patterns of small bowel cancer in a population-based study in Sweden: increase in duodenal adenocarcinoma. Cancer Epidemiol. 2012;36:e158\u201363.","journal-title":"Cancer Epidemiol"},{"key":"3568_CR2","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1245\/s10434-011-2173-6","volume":"19","author":"MJ Overman","year":"2012","unstructured":"Overman MJ, Hu C-Y, Kopetz S, Abbruzzese JL, Wolff RA, Chang GJ. A population-based comparison of adenocarcinoma of the large and small intestine: insights into a rare disease. Ann Surg Oncol. 2012;19:1439\u201345.","journal-title":"Ann Surg Oncol"},{"key":"3568_CR3","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1080\/0284186X.2016.1182211","volume":"55","author":"LM Legu\u00e9","year":"2016","unstructured":"Legu\u00e9 LM, Bernards N, Gerritse SL, van Oudheusden TR, de Hingh IHJT, Creemers G-JM, et al. Trends in incidence, treatment and survival of small bowel adenocarcinomas between 1999 and 2013: a population-based study in The Netherlands. Acta Oncol. 2016;55:1183\u20139.","journal-title":"Acta Oncol"},{"key":"3568_CR4","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1001\/jamaoncol.2017.1051","volume":"3","author":"AB Schrock","year":"2017","unstructured":"Schrock AB, Devoe CE, McWilliams R, Sun J, Aparicio T, Stephens PJ, et al. Genomic profiling of small-bowel adenocarcinoma. JAMA Oncol. 2017;3:1546\u201353.","journal-title":"JAMA Oncol"},{"key":"3568_CR5","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.3390\/cancers14051287","volume":"14","author":"K Pandya","year":"2022","unstructured":"Pandya K, Overman MJ, Gulhati P. Molecular landscape of small bowel adenocarcinoma. Cancers. 2022;14:1287.","journal-title":"Cancers"},{"key":"3568_CR6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s00535-021-01841-9","volume":"57","author":"K Nakagawa","year":"2022","unstructured":"Nakagawa K, Sho M, Okada K-I, Akahori T, Aoyama T, Eguchi H, et al. Surgical results of non-ampullary duodenal cancer: a nationwide survey in Japan. J Gastroenterol. 2022;57:70\u201381.","journal-title":"J Gastroenterol"},{"key":"3568_CR7","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/sj.bjc.6605449","volume":"102","author":"MJ Overman","year":"2010","unstructured":"Overman MJ, Pozadzides J, Kopetz S, Wen S, Abbruzzese JL, Wolff RA, et al. Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine. Br J Cancer. 2010;102:144\u201350.","journal-title":"Br J Cancer"},{"key":"3568_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1007200","volume":"14","author":"UA H\u00e4nninen","year":"2018","unstructured":"H\u00e4nninen UA, Katainen R, Tanskanen T, Plaketti R-M, Laine R, Hamberg J, et al. Exome-wide somatic mutation characterization of small bowel adenocarcinoma. PLoS Genet. 2018;14:e1007200.","journal-title":"PLoS Genet"},{"key":"3568_CR9","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1016\/j.ejca.2014.04.007","volume":"50","author":"A Laforest","year":"2014","unstructured":"Laforest A, Aparicio T, Zaanan A, Silva FP, Didelot A, Desbeaux A, et al. ERBB2 gene as a potential therapeutic target in small bowel adenocarcinoma. Eur J Cancer. 2014;50:1740\u20136.","journal-title":"Eur J Cancer"},{"key":"3568_CR10","doi-asserted-by":"publisher","first-page":"3641","DOI":"10.1158\/1078-0432.CCR-21-0159","volume":"27","author":"KS Pedersen","year":"2021","unstructured":"Pedersen KS, Foster NR, Overman MJ, Boland PM, Kim SS, Arrambide KA, et al. ZEBRA: a multicenter phase II study of pembrolizumab in patients with advanced small-bowel adenocarcinoma. Clin Cancer Res. 2021;27:3641\u20138.","journal-title":"Clin Cancer Res"},{"key":"3568_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/JCO.19.02105","volume":"38","author":"A Marabelle","year":"2020","unstructured":"Marabelle A, Le DT, Ascierto PA, Di Giacomo AM, De Jesus-Acosta A, Delord J-P, et al. Efficacy of pembrolizumab in patients with noncolorectal high microsatellite instability\/mismatch repair-deficient cancer: results from the phase II KEYNOTE-158 study. J Clin Oncol. 2020;38:1\u201310.","journal-title":"J Clin Oncol"},{"key":"3568_CR12","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.cell.2020.07.005","volume":"182","author":"CM Sch\u00fcrch","year":"2020","unstructured":"Sch\u00fcrch CM, Bhate SS, Barlow GL, Phillips DJ, Noti L, Zlobec I, et al. Coordinated cellular neighborhoods orchestrate antitumoral immunity at the colorectal cancer invasive front. Cell. 2020;182:1341\u2013.e19.","journal-title":"Cell"},{"key":"3568_CR13","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/ags3.12875","volume":"9","author":"S Doi","year":"2025","unstructured":"Doi S, Yasuda S, Miyashita M, Nagai M, Nakamura K, Matsuo Y, et al. Prognostic relevance of sarcopenia and tumor-infiltrating CD8+ T cells in patients with hepatocellular carcinoma. Ann Gastroenterol Surg. 2025;9:359\u201368.","journal-title":"Ann Gastroenterol Surg"},{"key":"3568_CR14","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402\u20138.","journal-title":"Methods"},{"key":"3568_CR15","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1097\/XCS.0000000000000808","volume":"237","author":"Y Imazu","year":"2023","unstructured":"Imazu Y, Nishiwada S, Yasuda S, Nagai M, Nakamura K, Matsuo Y, et al. Identification of nectin family interactive gene panel and stratification of clinical outcomes in patients with pancreatic cancer. J Am Coll Surg. 2023;237:719\u201330.","journal-title":"J Am Coll Surg"},{"key":"3568_CR16","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adh9069","volume":"9","author":"H Oyoshi","year":"2023","unstructured":"Oyoshi H, Du J, Sakai SA, Yamashita R, Okumura M, Motegi A, et al. Comprehensive single-cell analysis demonstrates radiotherapy-induced infiltration of macrophages expressing immunosuppressive genes into tumor in esophageal squamous cell carcinoma. Sci Adv. 2023;9:eadh9069.","journal-title":"Sci Adv"},{"key":"3568_CR17","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000053","volume":"10","author":"SS Thiruvengadam","year":"2019","unstructured":"Thiruvengadam SS, O\u02bcMalley M, LaGuardia L, Lopez R, Wang Z, Shadrach BL, et al. Gene expression changes accompanying the duodenal adenoma-carcinoma sequence in familial adenomatous polyposis. Clin Transl Gastroenterol. 2019;10:e00053.","journal-title":"Clin Transl Gastroenterol"},{"key":"3568_CR18","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3568_CR19","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transplant. 2013;48:452\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"3568_CR20","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1056\/NEJMoa1709684","volume":"377","author":"JD Wolchok","year":"2017","unstructured":"Wolchok JD, Chiarion-Sileni V, Gonzalez R, Rutkowski P, Grob J-J, Cowey CL, et al. Overall survival with combined nivolumab and ipilimumab in advanced melanoma. N Engl J Med. 2017;377:1345\u201356.","journal-title":"N Engl J Med"},{"key":"3568_CR21","doi-asserted-by":"publisher","first-page":"4435","DOI":"10.1158\/1078-0432.CCR-20-0482","volume":"27","author":"YR Miao","year":"2021","unstructured":"Miao YR, Thakkar KN, Qian J, Kariolis MS, Huang W, Nandagopal S, et al. Neutralization of PD-L2 is essential for overcoming immune checkpoint blockade resistance in ovarian cancer. Clin Cancer Res. 2021;27:4435\u201348.","journal-title":"Clin Cancer Res"},{"key":"3568_CR22","doi-asserted-by":"publisher","first-page":"e008977","DOI":"10.1136\/jitc-2024-008977","volume":"12","author":"TJ Moon","year":"2024","unstructured":"Moon TJ, Ta HM, Bhalotia A, Paulsen KE, Hutchinson DW, Arkema GM, et al. Nanoparticles targeting immune checkpoint protein VISTA induce potent antitumor immunity. J Immunother Cancer. 2024;12:e008977.","journal-title":"J Immunother Cancer"},{"key":"3568_CR23","doi-asserted-by":"crossref","unstructured":"Ren X, Peng M, Xing P, Wei Y, Galbo PM Jr., et al. Blockade of the immunosuppressive KIR2DL5\/PVR pathway elicits potent human NK cell-mediated antitumor immunity. J Clin Investig. 2022;132:e163620.","DOI":"10.1172\/JCI163620"},{"key":"3568_CR24","doi-asserted-by":"crossref","unstructured":"Tu E, McGlinchey K, Wang J, Martin P, Ching SL, Floc\u2019h N, et al. Anti-PD-L1 and anti-CD73 combination therapy promotes T cell response to EGFR-mutated NSCLC. JCI Insight. 2022;7:e142843.","DOI":"10.1172\/jci.insight.142843"},{"key":"3568_CR25","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1158\/2159-8290.CD-19-0541","volume":"9","author":"X-Y Li","year":"2019","unstructured":"Li X-Y, Moesta AK, Xiao C, Nakamura K, Casey M, Zhang H, et al. Targeting CD39 in cancer reveals an extracellular ATP- and inflammasome-driven tumor immunity. Cancer Discov. 2019;9:1754\u201373.","journal-title":"Cancer Discov"},{"key":"3568_CR26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13045-021-01080-8","volume":"14","author":"K Tang","year":"2021","unstructured":"Tang K, Wu Y-H, Song Y, Yu B. Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy. J Hematol Oncol. 2021;14:68.","journal-title":"J Hematol Oncol"},{"key":"3568_CR27","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1200\/JCO.18.02018","volume":"37","author":"BI Sikic","year":"2019","unstructured":"Sikic BI, Lakhani N, Patnaik A, Shah SA, Chandana SR, Rasco D, et al. First-in-human, first-in-class phase I trial of the anti-CD47 antibody Hu5F9-G4 in patients with advanced cancers. J Clin Oncol. 2019;37:946\u201353.","journal-title":"J Clin Oncol"},{"key":"3568_CR28","doi-asserted-by":"publisher","first-page":"981","DOI":"10.7150\/ijbs.79852","volume":"19","author":"S Zheng","year":"2023","unstructured":"Zheng S, Song J, Linghu D, Yang R, Liu B, Xue Z, et al. Galectin-9 blockade synergizes with ATM inhibition to induce potent anti-tumor immunity. Int J Biol Sci. 2023;19:981\u201393.","journal-title":"Int J Biol Sci"},{"key":"3568_CR29","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1158\/1078-0432.CCR-20-2584","volume":"27","author":"F Kontos","year":"2021","unstructured":"Kontos F, Michelakos T, Kurokawa T, Sadagopan A, Schwab JH, Ferrone CR, et al. B7-H3: an attractive target for antibody-based immunotherapy. Clin Cancer Res. 2021;27:1227\u201335.","journal-title":"Clin Cancer Res"},{"key":"3568_CR30","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1158\/1078-0432.CCR-22-2630","volume":"29","author":"K Kinneer","year":"2023","unstructured":"Kinneer K, Wortmann P, Cooper ZA, Dickinson NJ, Masterson L, Cailleau T, et al. Design and preclinical evaluation of a novel B7-H4-directed antibody-drug conjugate, AZD8205, alone and in combination with the PARP1-selective inhibitor AZD5305. Clin Cancer Res. 2023;29:1086\u2013101.","journal-title":"Clin Cancer Res"},{"key":"3568_CR31","doi-asserted-by":"publisher","first-page":"698677","DOI":"10.3389\/fimmu.2021.698677","volume":"12","author":"A Lin","year":"2021","unstructured":"Lin A, Yan W-H. HLA-G\/ILTs targeted solid cancer immunotherapy: opportunities and challenges. Front Immunol. 2021;12:698677.","journal-title":"Front Immunol"},{"key":"3568_CR32","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","volume":"375","author":"M Reck","year":"2016","unstructured":"Reck M, Rodr\u00edguez-Abreu D, Robinson AG, Hui R, Cs\u0151szi T, F\u00fcl\u00f6p A, et al. Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer. N Engl J Med. 2016;375:1823\u201333.","journal-title":"N Engl J Med"},{"key":"3568_CR33","doi-asserted-by":"publisher","first-page":"1344272","DOI":"10.3389\/fimmu.2024.1344272","volume":"15","author":"P Ouyang","year":"2024","unstructured":"Ouyang P, Wang L, Wu J, Tian Y, Chen C, Li D, et al. Overcoming cold tumors: a combination strategy of immune checkpoint inhibitors. Front Immunol. 2024;15:1344272.","journal-title":"Front Immunol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03568-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03568-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03568-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:57:23Z","timestamp":1792166243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03568-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,11,5]]}},"alternative-id":["3568"],"URL":"https:\/\/doi.org\/10.1038\/s41416-026-03568-x","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"assertion":[{"value":"15 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study was approved by the Institutional Review Board of Nara Medical University (approval number: 3922) and conformed to the provisions of the Declaration of Helsinki. Informed consent was obtained in the form of an opt-out option.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All authors consented to publication of this manuscript.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Ethics"}}]}}